首页> 外文会议>Collegium Internationale Allergologicum >Mechanisms of Inhibition of Human Allergic Th2 Immune Responses by Regulatory T-Cells Induced by Interleukln 10-Treated Dendritic Cells and Transforming Growth Factor beta
【24h】

Mechanisms of Inhibition of Human Allergic Th2 Immune Responses by Regulatory T-Cells Induced by Interleukln 10-Treated Dendritic Cells and Transforming Growth Factor beta

机译:通过白细胞uck10-处理的树突细胞和转化生长因子β诱导的调节T细胞抑制人过敏Th2免疫应答的机制,转化生长因子β

获取原文

摘要

Background: In grass pollen allergic individuals T-cell anergy can be induced by IL-10-treated dendritic cells (IL-10-DC) resulting in a decreased proliferation and Th1 as well as Th2 cyto-kine production. This study was set out to analyze whether such anergic T-cells are able to suppress the function of other T-cells and to analyze the role of TGF-beta as potential inducer of regulatory T-cells (Treg) in the periphery in this system. Methods: Freshly isolated CD4~+ or CD4~+ CD25- T-cells from grass pollen allergic donors were stimulated with autologous mature monocyte-derived allergen-pulsed dendritic cells in the presence or absence of T-cells previously cultured with IL-10-DC- and/or TGF-beta. Results: Anergic T-cells induced by allergen-pulsed IL- 10-treated DC or allergen-pulsed DC and TGF-P alone enhanced IL-10 production and strongly inhibited IFN-gamma production of fresh peripheral CD4~+ or CD4~+ CD25~- T-cells while proliferation and Th2 cytokine production were only slightly reduced. The addition of TGF-beta or the use of allergen-pulsed IL-10-treated DC and TGF-P had an additional effect leading to a much stronger suppression of Th2 cytokine production and proliferation. Suppression was not antigen-specific and was mainly mediated by cell-to-cell contact and by the molecule programmed death-1 (PD-1) and only partially by CTLA-4, TGF-beta and IL-10. Conclusions: These data demonstrate that regulatory/suppressor T-cells that also suppress Th2 cytokine production are induced most efficiently by DC that had been pretreated with IL-10 and by TGF-beta. This might be exploited for future therapeutic strategies for allergic diseases.
机译:背景:在草花粉中,过敏性质可以由IL-10处理的树突细胞(IL-10-DC)诱导T细胞毒性,导致增殖和TH1的增殖和Th1和Th2细胞产生。本研究旨在分析这种干燥的T细胞是否能够抑制其他T细胞的功能,并分析TGF-β作为该系统外周中的调节T细胞(Treg)的潜在诱导剂的作用。方法:将新鲜分离的CD4 +或CD4 + CD25 - 从草花粉过敏供体的T细胞用在预先用培养的T细胞的存在或不存在的自体成熟单核细胞来源的变应原 - 刺激的树突细胞刺激的IL-10- dc-和/或tgf-beta。结果:通过过敏原 - 脉冲IL-10-处理的DC或过敏原 - 脉冲DC和TGF-P诱导的接种T细胞增强的IL-10产生,强烈抑制新的外周CD4〜+或CD4〜+ CD25的IFN-Gamma生产〜 - T细胞,而增殖和Th2细胞因子产生仅略微减少。添加TGF-β或使用过敏原 - 脉冲IL-10-处理的DC和TGF-P具有额外的效果,导致Th2细胞因子产生和增殖的更强抑制。抑制不是抗原特异性的,主要是通过细胞对细胞接触和分子进行介导的死亡-1(PD-1),并且仅部分由CTLA-4,TGF-β和IL-10部分。结论:这些数据表明,调节/抑制T细胞,其抑制TH2细胞因子产生的DC最有效地用IL-10和TGF-β预处理的DC诱导。这可能会促进过敏性疾病的未来治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号